Overcoming the clinical challenges of traditional ayahuasca: a first-in-human trial exploring novel routes of administration of N,N-Dimethyltryptamine and harmine
first_published_at:Nov. 27, 2023, midnight / date_published:Nov. 27, 2023
Papers
-
27/11/2023 -
by
Dario A. Dornbierer,
Laurenz Marten,
Jovin Mueller,
Helena D. Aicher,
Michael J. Mueller,
Martina Boxler,
Michael Kometer,
Davor Kosanic,
Robin Von Rotz,
Maxim Puchkov,
Thomas Kraemer,
Hans-Peter Landolt,
Erich Seifritz,
Milan Scheidegger
Recently, the plant medicine "ayahuasca" from the Amazon, which contains the psychedelic compound N,N-dimethyltryptamine (DMT) and various β-carboline alkaloids like harmine, has been proposed as having positive effects in individuals …
